CompaniesMagnis Therapeutics

Magnis Therapeutics

defunct
About

Defunct Company

Areas of Focus

Categories

MergedBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (1)
View all

Total Trials

1

As Lead Sponsor

1

As Collaborator

0

Total Enrollment

78

By Phase

PHASE2: 1

By Status

COMPLETED: 1
Clinical Trials Pipeline1 trial
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2024
2025
2026
Today
Hover over trial bars to see details

Recent Trials

NCT06728553Lead Sponsor
Safety and Efficacy Trial of MTX101 2mg for the Acute Treatment of Migraine in Adults
PHASE2Completed
78 participants
Started: Feb 24, 2025 · Completed: Jul 28, 2025
Related Companies
Omnis Pharmaceuticals
merged
Magnis Therapeutics | Biotech Hunter | Biotech Hunter